Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

NCT00003861

Conditions
Acute Lymphoblastic Leukemia, Acute Promyelocytic Leukemia, Hematologic Diseases, +13 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 51 locations
View Trial Details
Active, not recruiting

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

NCT04613557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Nyu Langone Hospitals New York, United States
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
View Trial Details
Active, not recruiting

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

NCT02665065

Conditions
AML, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

NCT03948035

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Univ. Klinikum Krems Krems, Lower Austria, Austria
  • Universitätklinikum St. Pölten Sankt Pölten, Lower Austria, Austria
  • LKH-Universitätsklinikum Graz Graz, Styria, Austria
  • Medizinische Universität Innsbruck Innsbruck, Tyrol, Austria
View all 56 locations
View Trial Details
Active, not recruiting

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

NCT02415413

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital Universitari Germans Trias i Pujol Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
View all 16 locations
View Trial Details
Active, not recruiting

Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

NCT03645824

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
  • BE-Leuven-UZLEUVEN Leuven, Belgium
  • BE-Roeselare-AZDELTA Roeselare, Belgium
View Trial Details

Related conditions